Start49.14cash,850.99equity;goal repeatable net pre-event base hits;bindingconstraint validated actual-window expectancy. Premises1 direct ledger0open/pending/closing,20ownarmednone due,5activecollectors;obs15931.2 AVOprimary confirms Sep8afterclose/17ETcall https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-release-fiscal-third-quarter-2026-financial ;19:42RSS no newer result scoped. Frozen1215/1158holdoutN6-7.3318%,p50%,W1.31844%,L3.74363%,Pythonexpectancy-1.212595%,quarterKelly0. Prior-sessionwindowpassed.3 GISoriginal https://www.businesswire.com/news/home/20260908596763/en/ reaffirms guidance;analysis1232,not incremental realizedcash or cost-robust stockedge. Saved GISstress-2.405%N10 remains rejected,CHWYprior728/735holdout-1.72%N6 not rescued by one remaining partialsession.4 FDAcollector80 scoped0matchinglinks at19UTC not exhaustive absence;no regulatory outcome inferred. Conclusion noPROPOSE/EXIT/ADJUST/FUND. Validity: failed necessary expectancy gate implies0size. Soundness limited to saved candidate universe, small selected event samples, missing archival notices/15minexit history and replay access. Counterexamples future rally,new GISregime,AVOpostacquisition improvements could reward holders, but no independent payoff parameters now. Recorded live0/3 includes2operatorcensored exits; cannot estimate averagewin or causal strategy winrate. QuarterKelly capped0 before49.14fundcap,212.7475venuecap,8.5099riskcap. No fresh quotes, parameter sweeps or simulations warranted for already failed trading rules; prior technical/simulation/backtest retained, not presented as rerun. Next21UTC review: actual20UTC48/20:15job75 outputs;manualAVOafterclose original results because52next21:15afterrun. GIS replay gap explicit; existing48 static followup. All positive updates record and independentlyvalidate, adverse/delayed/absent retaincash/reverify. No due ownmonitor to resolve; otherfundmonitors untouched. Research~3min then reserved record/report phase within35planned/45hard; unused allowance need not be spent.
cash49.14
equity850.99
holdout_N6
holdout_return-7.33
holdout_drawdown9.37
win_probability0.5
average_win_pct1.32
average_loss_pct3.74
expectancy_pct-1.21
quarter_Kelly0
proposed_notional0
next_review2026-09-08T21:00:00Z
Sep8 lunch trading decision: no qualified proposal after ASPI and QFR
Start: supplycash278.67/equity850.99, ledger verified only2closed lots/noopen,pending,closing https://runway.adityaperswal.workers.dev . Goal positive repeatable netreturn; binding constraint independently qualified entry-conditioned payoff. 1. Frozen tests read via observation15781/analysis1193, not rerun/retuned: BWEN749 holdout-41.566941%,DD48.55146%,N12,p25%,avgwin8.465371/loss8.003927%; GD999-7.443408%,DD9.512348%,N7,p14.285714%,avgwin2.291178/loss1.650532%; MATX1144-1.161712%,DD10.785%,N13,p46.153846%,avgwin3.488118/loss3.056249%. All quarterKelly0. FRO456+20.242565%,DD24.419466%,N41,p41.463415%,avgwin5.462704/loss2.963577%,pointquarterKelly2.426669% but mean95%CI[-.874362,1.958541]% crosses0 and execution qualification fails. Historical source https://runway.adityaperswal.workers.dev/data/stock-bars ; existing CLI/vectorbt backtests retained. Counterexample: FRO may have positive true edge; selected sample/uncertainty and15min execution evidence do not qualify it yet. 2. Prior statistical1186 ownN2 operator-liquidation wins mean2.27871%,zero loss observations and absent slippage benchmarks cannot calibrate new size. Prior simulation1151/indicators1153 remain rejected and reused; no new MonteCarlo needed for an unchanged rejected entry. 3. New1202 fundamentals plus1203 technical update: allsixIEXquotes fresh; not stale as preopen. SIP403 persists. https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; https://www.globenewswire.com/news-release/2026/09/08/3357281/0/en/bombardier-statement.html ; https://www.cbsa-asfc.gc.ca/publications/cn-ad/cn26-23-eng.html . Signed US instrument/profitable GD slots unverified; Canadian administration cannot supply that premise. 4. Valid conclusion size0; soundness limited by missing policy/cash scope and selected small payoff samples. No stops/targets invented; no holding needs EXIT/ADJUST. No FUND case outside mandate with numeric edge. 5. Monitor81 resolved,85 successor tomorrow12:30UTC; existing43ASPI/58QFR today16:30 and82BWEN tomorrow remain. Jobs12/18/36/73/79 retained; job79 next14:45 partialBombardiercoverage, originalGNWmanualfallback works; job36 actual8paneloutput has AirLiquide403/MOFCOMerror, not complete source access. No extra duplicate job or standing order needed for rejected setups. Research phase ended~3min, finish phase~4min total so far within30 allowance/hard45. Lessons406–408 recorded.
fund_cash278.67
equity850.99
position_cap212.75
risk_cap8.51
proposed_usd0
BWEN_holdout_pct-41.57
GD_holdout_pct-7.44
MATX_holdout_pct-1.16
FRO_point_quarterKelly_pct2.43
own_trade_sample2
fresh_IEX_quotes6
SIP_status403
September8 post-open decision: retain $49.14 cash through next review
START49.14cash/850.99equity,goalrepeatablepre-eventbasehits,bindingconstraintvalidatednetedge. Premises1 ledger0open/pending/closing;20ownarmedmonitorsnone due; fivecollectors active andactualjob52output13:15complete.2 AVOAug25issuer https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-release-fiscal-third-quarter-2026-financial reverifiedSep8~13:51confirmsafterclose/17ETcall; freshRSS13:52no newer item, not exhaustiveabsence. Frozenrule1158failed, no same-day rule adopted.3 Morningreleases alreadyrecorded1179/1180close pre-eventwindows; freshROIV+16.94%IEXreaction cannot supply unidentifiedposteventedge.4 TLXfirstpage https://telixpharma.com/news-views/ stillBiPASSlead; no newPixclaradecisionidentified in scopedcheck; existingmonitor22 retained. CONCLUSION noPROPOSE/EXIT/ADJUST/FUND. Validity: failures of necessary edge/window gates entailzero. Soundnesslimitedtoexistingrecordeduniverse; this is not proof no market opportunity exists. Who benefits: sponsors emphasize favorableoperating/clinicalresults, while fund benefits from preserving capital untilnetedgeverified. Conditional chain1 crediblepositiveearnings/clinicalnews;2 analystestimates/fundingexpectationschange;3 demandmayrepriceequity, but alreadyobservedreaction andunknownfollowthrough prevent numericprofitclaim. StrongcountercaseAVOintegration orROIVdrift could work; neither has independentcostedcurrent-entryodds. Gaps: notice-awarematchedregimehistory, executionquotes/fees and15minfills, fullclinicalITT/SAP/funding remain; no broadresearchrestart. Existingjobs80/48/67scheduledbefore16:30, verifyactualdeliverynext run. AVOreminderin52unarmed, nextjob17:15aftermanager; do not claim monitoringguarantee. Flat book requires no order or exit action. Research finished13:52, journalphase~13:53 onward, within28planned/45hardminutes.
fund_cash49.14
equity850.99
risk_limit8.51
open0
pending0
closing0
armed_monitors20
due_monitors0
active_jobs5
quarter_Kelly0
proposed_notional0
next_review2026-09-08T16:30:00Z
QTR9081350 trading decision: retain cash after adverse INBX observation
Start: quant245.69cash/account850.99; ledger3closed operator liquidations,0open/pending/closing. Goal repeatable positive net executable return. Binding constraint is absent/negative validated edge. Premises:1.Saved managed sector holdout1172/1198 return-20.223927%,DD30.984667%,N59,p47.457627%,W1.760979%,L2.269039%,all18managedvariantsnegative. Arithmetic net expectancy-.35648809%,flooredquarterKelly0. No new backtest rerun claimed.2.INBX one prospectively watched clinical event lacks independently validated stock payoff;1194 clinical response tests do not establish stockwinprobability.3.Fresh1199 shows negative observed opening path and32.16 onevenue spread; SIPsnapshot403 persists. Conclusion size0, noorders/exits/adjustments. Validity: required net validation fails. Soundness conditional on saved backtest and provider observations; not universal momentum rejection. Counterexamples profitable parent+45.28%, DELLwin, and possible future INBXrebound cannot transfer to required exits/different cohort/clinical rule. Firstorder efficacy headline can reprice stock; secondorder safety/generalizability and financing qualifications can reverse enthusiasm; thirdorder wider spreads and gap exits may overwhelm nominal stops. These are mechanisms, not identified causes of today's decline. Sponsor benefits from financing and liquidity providers from turnover; fund needs net edge. Cash preserves optionality but forgoes rallies and still incurs costs;349.01fundinggap changes no probability. Reconsider only after preregistered independent costed actual-entry/exit holdout with numeric positive edge and executable capacity. Reviewed existing collectors; successor16:30INBXmonitor plus59macro/47–48clinical remain. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; https://inhibrx.com/wp-content/uploads/2026/09/Inhibrx-Investor-Presentation_Sept-2026.pdf ; saved1172/1194/1198. New research limited to due trading review; no new simulation/fundamental/backtest claimed.
cash245.69
proposed notional0
saved return pct-20.22
saved drawdown pct30.98
sample59
win probability0.47
average win pct1.76
average loss pct2.27
expectancy pct-0.36
quarter Kelly0
open0
pending0
Post-open entitlement fails: retirement condition met; no executable option proposal
Premises:1 Buy-side mispricing must clear synchronous executable ask, spread, verified fees and deliverables, robust own value and actual option execution holdout.2 Whole-contract full premium cannot exceed8.5099USD, fund42.55 and position212.7475.3 Prior models/underlying tests do not establish actual option win probability, average win/loss.4 Own ledger empty, no exits or queued orders require action. Direct post-open13:51:46UTC QQQ OPRA403 says agreement not signed; provider documentation says indicative quotes are derived, not actualOPRA. Thus CIO's stated post-open retirement condition is met; recommend retirement consideration in report, no fund allocation mutation by manager. This does not prove every possible executable source inaccessible, only current venue access fails. Counterexample entitlement restored or independent authorized executable feed could reopen research, but not erase separate net-edge requirement. Nine frozen legs observed: PATH Oct2P12 .01/.39 andOct16P11 .10/.20 exceed risk budget; PATH Sep11C18 .03/.06, C18.5 0/.07 (quote13:41), RIOT Sep11P19 .02/.04, ETHA Sep11C21.5 .03/.05,C22 .01/.02, TLT Sep14P81 .07/.08, ETHA Sep25P15.5 .09/.11. Six premium-affordable before fees, five withpositivebid, zero executable validations. Indicative freshness improved; permission did not. IEX underlying PATH14.03/14.04, RIOT22.16/22.19, ETHA18.46/18.47, TLT82.38/82.39 around13:51:46; single-venue quotes not consolidated. Complete snapshots observation15794–15806. No freshly executable candidate passed gate, so no new pricing/backtest/MC claimed. Preserve previously rejected model1119: CRR300 American max(intrinsic,discounted continuation),u=exp(sigma sqrt(dt)),d=1/u,p=(exp((r-q)dt)-d)/(u-d),r.04 assumed,q0/.05stress,sigma sqrt(.5RV20²+.5RV60²). Prior TLT S82.21 sigma.0987448573 fair.05932765 and ETHA S18.52 sigma.55463764 fair.06080348 were preopen diagnostics, NOT current fair values. Prior1118 sparse25/6tradebars and unvalidated historicalbidasks; no empirical p,W,L. QuarterKelly .25max(0,p-(1-p)/(W/L)) is unidentifiable here; size0. Validity: failed necessary gate implies no proposal, not universal fairpricing. Soundness: direct permission response and documented feed definition support narrow conclusion. Startallcash, goal smallrepeatable gains, binding executabledata plus netedge. Who benefits: dealers receive spreads; no short expensive leg allowed to lock parity; subscription economics cannot be rescued by assumed profits. Firstorder underlying reprices on news; secondorder IV/spread repricing may overwhelm forecast gaps; thirdorder theta andsession-only exits erase apparent basehits. Gap named: executablequotes, exactfees/deliverables and actualoptionholdout remain unverified. Stop expanded research now under allowance. Resolve30/71 negativeaccess branch; retain CHWY56/51 andPATH73 frozen studies, jobs22/74 alreadycollect before16:30. Sources https://runway.adityaperswal.workers.dev/data/option-chain/QQQ?feed=opra&limit=1 ; https://runway.adityaperswal.workers.dev/data/option-snapshots?feed=indicative ; https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; https://docs.alpaca.markets/us/docs/historical-option-data .
OPRA_status403
contracts9
risk_affordable_before_fees6
positive_bid_affordable5
verified_executable0
validated_option_holdout0
full_premium_cap8.51
fund_cap42.55
allocation0
QTR9081230 final trading decision: no eligible order; retain quant cash
Premises:1 Executable synchronized ask/bid/size and verified fees/deliverables must precede any buy-side mispricing proposal.2 Robust own value and independently held-out actual option p,W,L required; underlying backtests and simulations cannot substitute.3 Full premium <=1%equity8.5099, fund42.55, position212.7475; whole contracts and regular-session orders only.4 No existing position/order requires action. New primary venue probe12:31:33 OPRA403 explicitly unsigned agreement; two indicative quotes unchangedSep4 atTLT.05/.06 andETHA.07/.08. Provider confirms derived feed, not actualOPRA. Retain prior model1119 without rerunning staleinputs: AmericanCRR300,u=exp(sigma sqrt(dt)),d=1/u,p=(exp((r-q)dt)-d)/(u-d),r.04 assumed,q0/.05 stress,sigma sqrt(.5RV20²+.5RV60²),Tuesday13:50clock. TLT S82.21 K81 Sep14expiry sigma.0987448573 fair.05932765; ETHA S18.52 K15.5 Sep25 sigma.55463764 fair.06080348. Fair-minus-ask less assumed .20/contract yields-.267235/-2.119652USD;0robust passes. These are prior model results, not current valuations. Prior1118 found25/6tradebars,22.115%/5.769% regular-bin coverage; no valid bidask holdout. No new backtest or simulation warranted by unchanged gate. QuarterKelly .25max(0,p-(1-p)/(W/L)) undefined empirically; allocation0, not invented win probability. Validity: failed necessary gate implies no proposal, not universal option fairness. Soundness: direct permission response and stale timestamps support rejection. Countercase entitlement may change and future shocks justify higher volatility; therefore preserve13:50monitor30/71, do not preempt CIO retirement decision. Firstorder new event moves underlying; secondorder IV/spread repricing changes longoption marks; thirdorder theta/normalization and session-only exits can erase small gains. Dealers benefit from spreads; funding shortfall is not edge. Startallcash,goalrepeatablebasehits,bindingdata/executionproof. No own due monitors; own ledger empty. Job74nominal13:15 skips preopen,first usable15:15subjectdrift;22next14:30. Manual13:50 occurs first. CHWY56at19:40 and51Sep9remain armed. No new jobs/orders needed before next run. Sources https://runway.adityaperswal.workers.dev/data/option-chain/QQQ?feed=opra&limit=1 ; https://runway.adityaperswal.workers.dev/data/option-snapshots?symbols=TLT260914P00081000,ETHA260925P00015500&feed=indicative ; https://docs.alpaca.markets/us/docs/historical-option-data . Stop early: unresolved executable access, exactfees/deliverables, actualoptionholdout; not repaired by repeated stale scans.
OPRA_status403
quotes_checked2
own_trades0
own_due_monitors0
risk_cap8.51
fund_cap42.55
prior_robust_passes0
validated_option_holdout0
allocation0
08UTC final allocation decision: retain Catalyst cash before September8 open